Michael Farrell
For ResMed Corp, San Diego, the process of research and new product development is key to the respiratory medical device manufacturer keeping its products for the diagnosis and treatment of sleep disordered breathing competitive. Sleep Review spoke with ResMeds vice president of marketing, Michael Farrell, about where the sleep therapy equipment market is heading and the companys latest device.
SR: What is the latest trend in sleep therapy equipment? Farrell: Lifestyle. Patients are having more and more say in their health care decisions, and sleep apnea is no exception. We have focused on three core trends in our latest line of products, which means that they had to pass the Three Cs test: compact, convenient, and comfortable. Our S8 flow generator is the size of a bedside clock radio, and our Mirage Swift nasal pillows interface is not much bigger than a Robusto-sized cigarthese products are really compact. They are also convenient. The S8 is portable from room to room and can even be used while traveling domestically and internationallythey can even be used in automobiles and while camping with 24V and 12V batteries. I have heard of patients using the S8 and Swift on trains, cruise ships, and even hiking the Inca trail. The final area is comfort. Our S8 line has the AutoSet algorithm, the best automatic adjusting PAP system on the planet, and EPR, a comfort feature that can be turned off after ramp or when respiratory events occur outside of physician-prescribed parameters. The unit can then revert to standard CPAP to ensure comfortable treatment, without compromise of clinical efficacy.
SR: How does ResMed spot trends and how does the company respond to them? Farrell: ResMed is focused on the long-term. Our Lasting Results marketing theme speaks clearly to this. We are focused on complete product and service solutions, quality systems in product development and manufacturing, and delivery of reliable and top-quality products. So, in terms of market needs and trends, we focus on the long-term voice of the customer. The complexity comes when you ask: Who is the customer? The answer is multivariate. Sleep specialist physicians and technicians, respiratory therapists, home medical equipment providers, and patients are all our customers. The integration of long-term voice of the customer feedback across this group is quite an art; it includes listening to our key opinion leaders in the field and boiling down to the fundamental current and latent needs of the customer group. The key is execution, which means ensuring we get to market with a reliable and high-quality product before the competition. Our track record of growth indicates that we get this right. I believe our S8 and Mirage Swift products have taken, and will continue to take, this market by storm. We are always looking over the horizon at what is next.
SR: How has ResMed positioned the new VPAP Adapt SV? What types of SDB patients can be treated with this product? Farrell: The VPAP Adapt SV is an adaptive servo-ventilator that treats central sleep apnea, mixed sleep apnea, and periodic breathing, including Cheyne-Stokes respiration. We have thousands of patients on treatment with this device in Europe and have just completed our US Food and Drug Administration clearance work. This product can literally normalize a complex Cheyne-Stokes breathing pattern in a matter of minutes. Sleep technicians who have watched it work have called it miraculous. The MD/PhD team that created it certainly worked wonders, and now, we have the product cleared for use in our own US market. Finally, there is a one-stop solution for patients who have central or mixed sleep apnea and/or periodic breathing. VPAP Adapt SV is the product of choicehighly technically advanced, yet easy for technicians and patients to use. It will be available to the market in early 2006. |